Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could stem cell particles help treat rare muscle weakness disorder?

NCT ID NCT07226726

First seen Nov 11, 2025 · Last updated May 25, 2026 · Updated 24 times

Summary

This early-phase trial tests whether a solution made from stem cell particles (exosomes) can help people with congenital myasthenic syndrome, a rare genetic condition causing muscle weakness. About 20 participants will receive the treatment and be monitored for safety and oxygen levels. The goal is to see if this approach is safe and might improve muscle function.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONGENITAL MYASTHENIC SYNDROME are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Medical Surgical Associates Center

    RECRUITING

    St John's, Antigua and Barbuda

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Prodromos Stem Cell Institute

    RECRUITING

    Naples, Florida, 34102, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Prodromos Stem Cell Institute

    RECRUITING

    Irving, Texas, 75039, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.